What is the reimbursement rate for Cathflo when used to restore function to a central venous access device?
Effective beginning January 1, 2008, the national reimbursement rate for Medicare patients receiving Cathflo in a hospital outpatient setting is set at Average Sales Price (ASP) plus 5% (published quarterly by the Centers for Medicare and Medicaid Services). Genentech cannot guarantee the exact amount of money, if any, your clinic or office will receive. If you need further assistance regarding Medicare or Medicaid reimbursement policies or procedures, please contact your local carrier directly.
Related Questions
- What billing code does a physicians office use for administration of Cathflo to restore function to a central venous access device (CVAD)?
- What is the reimbursement rate for Cathflo when used to restore function to a central venous access device?
- What is the reimbursement rate for Cathflo when used to restore function to central venous access devices?
